Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00524264 · ClinicalTrials.gov registry record · Phase 3
A Study of Ketorolac for the Treatment of Inflammation and Pain Associated With Cataract Surgery
A Phase 3 study of Pain and Inflammation, sponsored by Allergan.
- Completed
- Registry status
- Phase 3
- Development phase
- 248
- Enrollment target
- 1
- Study location
NCT00524264 is a Phase 3 study of Pain and Inflammation that has completed, run by Allergan. The registered enrollment target is 248 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (18% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00524264, a Phase 3 study of Pain and Inflammation, has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 248 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a 16-day study to evaluate the safety and efficacy of ketorolac eye drops for the treatment of inflammation and pain associated with cataract surgery.
Conditions Studied
Interventions
- DRUG ketorolac
Study Locations (1)
California
- - Artesia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 248 participants |
| Start Date | 2007-10 |
| Est. Completion | 2008-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00524264
The ClinicalTrials.gov registry entry for NCT00524264 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 248 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (18% lower). The listed sponsor is Allergan, which has 314 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Pain appearing as the primary indexed condition, and to 1 intervention - of which ketorolac is the first listed.
NCT00524264 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00524264 about?
NCT00524264 is a clinical study titled "A Study of Ketorolac for the Treatment of Inflammation and Pain Associated With Cataract Surgery". This is a 16-day study to evaluate the safety and efficacy of ketorolac eye drops for the treatment of inflammation and pain associated with cataract surgery.
What is the current status of trial NCT00524264?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 248 participants. The study started on 2007-10. Estimated completion is 2008-04.
What conditions does trial NCT00524264 study?
This clinical trial studies the following conditions: Pain, Inflammation, Cataract Extraction.
What interventions are being tested in trial NCT00524264?
The interventions under investigation include: ketorolac (DRUG).
Who is sponsoring clinical trial NCT00524264?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00524264 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of NSAIDs on Union, Opioid Utilization and Pain Management for Tibia Fractures: A Pragmatic, Randomized Controlled Trial
RECRUITING · Phase 3
-
Opioid-Free Orthopaedics
RECRUITING · Phase 3
-
Suzetrigine in Total Hip Arthroplasty
RECRUITING · Phase 3
-
Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits
RECRUITING · Phase 3
-
Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment
RECRUITING · Phase 3
-
Post-Op Pain Control for Prophylactic Intramedullary Nailing.
RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.